-
Investor Relations
Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases.
Stock Chart
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Stock Chart
Data Provided by Refinitiv. Minimum 15 minutes delayed.